2015 marked a pivotal year for biosimilars, offering those suffering from chronic illness increased patient access to new therapeutic options. As we look forward to the upcoming year, Biologics Prescribers Collaborative resolves to continue our commitment to ensure that sound policies are in place to promote the safest possible use of all biologics, including biosimilars, for all patients.
